Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and III.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples